Expanding Access to Obesity Medications Could Avert 42,000 Deaths/Year

THURSDAY, Nov. 7, 2024-- Expanding access to obesity medications such as glucagon-like peptide 1 (GLP-1) receptor agonists and dual gastric inhibitory polypeptide and GLP-1 receptor agonists could avert 42,000 deaths annually in the United States...